NCT06482905 2026-01-06Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.Tcelltech Inc.Phase 1 Recruiting52 enrolled
NCT06598787 2025-05-07A Study of BL-B01D1 in Patients With Recurrent GlioblastomaSichuan Baili Pharmaceutical Co., Ltd.Phase 2 Recruiting20 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled